James Samuel Shannon - Net Worth and Insider Trading

James Samuel Shannon Net Worth

The estimated net worth of James Samuel Shannon is at least $4 Million dollars as of 2024-09-20. James Samuel Shannon is the Director of Horizon Therapeutics PLC and owns about 33,604 shares of Horizon Therapeutics PLC (HZNP) stock worth over $4 Million. Details can be seen in James Samuel Shannon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Samuel Shannon has not made any transactions after 2021-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Samuel Shannon

To

James Samuel Shannon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Samuel Shannon owns 3 companies in total, including Horizon Therapeutics PLC (HZNP) , MannKind Corp (MNKD) , and Endocyte Inc (ECYT) .

Click here to see the complete history of James Samuel Shannon’s form 4 insider trades.

Insider Ownership Summary of James Samuel Shannon

Ticker Comapny Transaction Date Type of Owner
HZNP Horizon Therapeutics PLC 2021-03-01 director
MNKD MannKind Corp 2010-02-24 director
ECYT Endocyte Inc 2011-05-26 director

James Samuel Shannon Latest Holdings Summary

James Samuel Shannon currently owns a total of 1 stock. James Samuel Shannon owns 33,604 shares of Horizon Therapeutics PLC (HZNP) as of March 1, 2021, with a value of $4 Million.

Latest Holdings of James Samuel Shannon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HZNP Horizon Therapeutics PLC 2021-03-01 33,604 116.30 3,908,145

Holding Weightings of James Samuel Shannon


James Samuel Shannon Form 4 Trading Tracker

According to the SEC Form 4 filings, James Samuel Shannon has made a total of 1 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 7,232 shares on March 1, 2021, which brought James Samuel Shannon around $660,282.

Insider Trading History of James Samuel Shannon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Samuel Shannon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James Samuel Shannon Ownership Network

Ownership Network List of James Samuel Shannon

No Data

Ownership Network Relation of James Samuel Shannon

Insider Network Chart

James Samuel Shannon Owned Company Details

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

James Samuel Shannon is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Horizon Therapeutics PLC Insider Transactions

No Available Data

James Samuel Shannon Mailing Address

Above is the net worth, insider trading, and ownership report for James Samuel Shannon. You might contact James Samuel Shannon via mailing address: 28903 North Avenue Paine, Valencia Ca 91355.

Discussions on James Samuel Shannon

No discussions yet.